房颤或房扑住院后的长期结局:10年随访研究
研究纳入澳大利亚和新西兰2008-17年因房颤或房扑急性住院的260 492例成人,随访至10年。结果显示1年生存率91.2%、5年72.7%、10年55.2%,平均预期寿命损失2.6年(16.8%);10年内心衰、卒中、心梗再住院累积发生率分别为16.8%、11.0%、7.1%,房颤/房扑再住院达41.2%,导管消融仅6.5%。
要点
- 房颤/房扑住院后10年生存率仅55.2%,预期寿命平均损失2.6年。
- 10年内房颤/房扑再住院率41.2%,心衰再住院16.8%,卒中11.0%。
- 10年内接受导管消融者仅6.5%,提示治疗应用不足。
核心结论
- 因房颤或房扑住院的患者死亡风险高,平均预期寿命损失2.6年。
- 房颤/房扑再住院及心衰、卒中等相关结局常见,而导管消融使用率低。
研究设计与样本
- 基于澳大利亚和新西兰2008-17年所有公立及多数私立医院的住院数据,纳入因房颤或房扑急性住院的260 492例成人(平均年龄70.5±14.4岁,49.6%女性)。
- 采用Kaplan-Meier法估计生存率,灵活参数生存模型估计预期寿命损失,竞争风险模型(考虑死亡)估计非致死性结局累积发生率。
主要发现
- 随访1 068 009人年,期间69 167例死亡(发生率6.5/100人年),1年生存率91.2%、5年72.7%、10年55.2%。
- 预期寿命损失2.6年,占预期寿命的16.8%。
- 10年累积再住院率:心衰16.8%(2.9/100人年)、卒中11.0%(1.7/100人年)、心梗7.1%(1.1/100人年)。
- 房颤/房扑再住院1年21.3%、5年35.3%、10年41.2%(11.6/100人年)。
- 10年导管消融累积发生率6.5%(1.2/100人年)。
临床怎么用
- 对房颤/房扑住院患者应加强长期随访管理,关注高死亡风险及再住院风险。
- 重视心衰、卒中等相关结局的预防和监测,并评估导管消融等节律控制的适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Atrial fibrillation (AF) and flutter are common causes of hospitalizations but contemporary long-term outcomes following these episodes are uncertain. This study assessed outcomes up to 10 years after an acute AF or flutter hospitalization. METHODS: Patients hospitalized acutely with a primary diagnosis of AF or flutter from 2008-17 from all public and most private hospitals in Australia and New Zealand were included. Kaplan-Meier methods and flexible parametric survival modelling were used to estimate survival and loss in life expectancy, respectively. Competing risk model accounting for death was used when estimating incidence of non-fatal outcomes. RESULTS: A total of 260 492 adults (mean age 70.5 ± 14.4 years, 49.6% female) were followed up for 1 068 009 person-years (PY), during which 69 167 died (incidence rate 6.5/100 PY) with 91.2% survival at 1 year, 72.7% at 5 years, and 55.2% at 10 years. Estimated loss in life expectancy was 2.6 years, or 16.8% of expected life expectancy. Re-hospitalizations for heart failure (2.9/100 PY), stroke (1.7/100 PY), and myocardial infarction (1.1/100 PY) were common with respective cumulative incidences of 16.8%, 11.0%, and 7.1% by 10 years. Re-hospitalization for AF or flutter occurred in 21.3% by 1 year, 35.3% by 5 years, and 41.2% by 10 years (11.6/100 PY). The cumulative incidence of patients undergoing catheter ablation of AF was 6.5% at 10 years (1.2/100 PY). CONCLUSIONS: Patients hospitalized for AF or flutter had high death rates with an average 2.6-year loss in life expectancy. Moreover, re-hospitalizations for AF or flutter and related outcomes such as heart failure and stroke were common with catheter ablation used infrequently for treatment, which warrant further actions.
引用
- Ngo, Peng, Denman, et al. Long-term outcomes after hospitalization for atrial fibrillation or flutter. Eur Heart J. 2024. PMID: 38678737. doi:10.1093/eurheartj/ehae204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。